Inova Diagnostics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Inova Diagnostics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6514
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Inova Diagnostics Inc (Inova), a subsidiary of Werfen Life Group SAU is a medical device company that develops and commercializes new autoimmune technologies and diagnostic markers. The company’s diagnostic reagent products include quanta flash used for semi-quantitative determination of auto-antibodies; quanta lite used to enable semi-quantitative detection of auto-antibodies in human serum; nova lite; nova dot; nova gel; and quanta chek. Inova provides automation instruments such as bio-flash, quanta link, nova view, quanta -lyser family of products, DSX/best 2000 and DS2. The company offers tests and technologies for the treatment of diseases such as celiac, anti-phospholipid syndrome, connective tissue, gastrointestinal, rheumatoid arthritis, vasculitis and other diseases. Inova is headquartered in San Diego, California, the US.

Inova Diagnostics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Inova Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Inova Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Inova Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Inova Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Inova Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Inova Diagnostics Inc, Medical Equipment, Deal Details 10
Partnerships 10
Inova Diagnostics Enters into Licensing Agreement with Hasselt University 10
Leiden University Enters Into Licensing Agreement With Inova Diagnostics For Rheumatoid Arthritis 11
INOVA Diagnostics Enters Into Licensing Agreement With AmberGen And Massachusetts General Hospital For Two Autoantigen Biomarkers 12
Inova Diagnostics Enters into Licensing Agreement with Protagen 13
Inova Diagnostics Inc – Key Competitors 14
Inova Diagnostics Inc – Key Employees 15
Inova Diagnostics Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Inova Diagnostics Inc, Medical Equipment, Key Facts 2
Inova Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Inova Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Inova Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Inova Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Inova Diagnostics Inc, Deals By Market, 2012 to YTD 2018 8
Inova Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Inova Diagnostics Enters into Licensing Agreement with Hasselt University 10
Leiden University Enters Into Licensing Agreement With Inova Diagnostics For Rheumatoid Arthritis 11
INOVA Diagnostics Enters Into Licensing Agreement With AmberGen And Massachusetts General Hospital For Two Autoantigen Biomarkers 12
Inova Diagnostics Enters into Licensing Agreement with Protagen 13
Inova Diagnostics Inc, Key Competitors 14
Inova Diagnostics Inc, Key Employees 15

List of Figures
Inova Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Inova Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Inova Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Inova Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Inova Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Inova Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Inova Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Inova Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Inova Diagnostics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Enusa Industrias Avanzadas, S.A., S.M.E:企業の戦略的SWOT分析
    Enusa Industrias Avanzadas, S.A., S.M.E - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Mutual Trust Bank Limited:企業の戦略・SWOT・財務情報
    Mutual Trust Bank Limited - Strategy, SWOT and Corporate Finance Report Summary Mutual Trust Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Eutelsat Communications Group:企業の戦略・SWOT・財務分析
    Eutelsat Communications Group - Strategy, SWOT and Corporate Finance Report Summary Eutelsat Communications Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Acarix AS:医療機器:M&Aディール及び事業提携情報
    Summary Acarix A/S (Acarix) is a medical device company that provides design and development of non-invasive cardiac screening products. The company provides non-invasive screening device, CADScor system used to record, process and display heart signals as a patient specific score as the CAD-score o …
  • Hoerbiger Holding AG:企業の戦略的SWOT分析
    Hoerbiger Holding AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Mymetics Corp (MYMX):製薬・医療:M&Aディール及び事業提携情報
    Summary Mymetics Corp (Mymetics) is a biotechnology company that develops next-generation prophylactic vaccines for infectious diseases. The company's product pipeline includes vaccine candidates that target HIV-1/AIDS, chikungunya, intranasal influenza, malaria, herpes simplex virus (HSV) and respi …
  • CONSOL Energy Inc.:企業の戦略・SWOT・財務情報
    CONSOL Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary CONSOL Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • China Singyes Solar Technologies Holdings Ltd (750):企業の財務・戦略的SWOT分析
    China Singyes Solar Technologies Holdings Ltd (750) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s ke …
  • Inovalon Holdings Inc (INOV):企業の財務・戦略的SWOT分析
    Summary Inovalon Holdings Inc (Inovalon), is a technology company that provides cloud-based platforms for healthcare industry. The company designs, develops and distributes software tools to provide healthcare and financial improvement solutions. It offers Inovalon ONE platform and provides data dri …
  • Pacific Edge Ltd (PEB)-医療機器分野:企業M&A・提携分析
    Summary Pacific Edge Ltd (PEB) is a diagnostics company that discovers, develops and commercializes diagnostic tests for the early detection and monitoring of cancer. The company provides lead product such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It is develo …
  • SRF Ltd (SRF):企業の財務・戦略的SWOT分析
    SRF Ltd (SRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Millendo Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Millendo Therapeutics Inc (Millendo Therapeutics), formerly Atterocor Inc is a drug development company that develops treatments for endocrine diseases including vasomotor. The company provides development of innovative treatments for orphan endocrine disorders such as adrenocortical carcino …
  • Ceylon Cold Stores PLC:企業の戦略・SWOT・財務情報
    Ceylon Cold Stores PLC - Strategy, SWOT and Corporate Finance Report Summary Ceylon Cold Stores PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Viracta Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Viracta Therapeutics Inc (Viracta) is a drug development company that develops medicine to address viral associated cancer. The company's kick and kill platform is designed to treat viral associated cancers and other serious diseases. Its product development pipeline includes ebv lymphoma, e …
  • Electronic Data Processing plc (EDP):企業の財務・戦略的SWOT分析
    Summary Electronic Data Processing plc (EDP), a subsidiary of Kerridge Commercial Systems Ltd, is a technology company that supplies computer services and solutions to merchants and distributors. The company offers hosting services, SaaS managed services, business continuity, service level agreement …
  • Keryx Biopharmaceuticals Inc (KERX)-製薬・医療分野:企業M&A・提携分析
    Summary Keryx Biopharmaceuticals Inc (Keryx) develops and commercializes new therapies for the treatment of renal disease. The company’s lead product Auryxia (ferric citrate) is an FDA approved oral, absorbable iron-based phosphate binder, which helps lower the amount of phosphate in human blood. Au …
  • Atomenergoprom:企業の戦略的SWOT分析
    Atomenergoprom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Gokul Refoils & Solvent Ltd. (GOKUL):企業の財務・戦略的SWOT分析
    Gokul Refoils & Solvent Ltd. (GOKUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Lear Corporation (LEA):企業の財務・戦略的SWOT分析
    Lear Corporation (LEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Power Grid Corporation of India Limited:企業の戦略・SWOT・財務情報
    Power Grid Corporation of India Limited - Strategy, SWOT and Corporate Finance Report Summary Power Grid Corporation of India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆